Screener
Coherus BioSciences CHRS Q2 2025 earnings
Reported August 7, 2025 · After market close
Revenue$10.3MMiss by $1.7M
EPS-$0.34Miss by $0.03
Revenue estimate$12.0M
EPS estimate-$0.31
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$16.0M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Coherus BioSciences report Q2 2025 earnings?
- Coherus BioSciences (CHRS) reported Q2 2025 earnings on August 7, 2025 after market close.
- What were Coherus BioSciences's Q2 2025 revenue and EPS?
- Coherus BioSciences reported revenue of $10.3M and eps of $-0.34 for Q2 2025.
- Did Coherus BioSciences beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $12.0M by $1.7M. EPS missed the consensus estimate of $-0.31 by $0.03.
- How did Coherus BioSciences's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 84.2% from $65.0M a year earlier and eps declined 142.9% from $-0.14.
- Where can I find Coherus BioSciences's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001558370-25-010802) and the 10-Q periodic report (0001558370-25-010803) directly on SEC EDGAR. The filing index links above go to sec.gov.
